Biotech and Pharmaceuticals

Eli Lilly Launches Zepbound KwikPen for More Convenient Weight Management Eli Lilly and Company announced on Monday the availability of a new delivery option for its blockbuster obesity drug, Zepbound …

Novo Nordisk on Monday said it is suing online telehealth provider Hims & Hers for mass marketing cheaper, unapproved copies of the drugmaker’s new Wegovy obesity pill and injections in …

Novo Nordisk shares jumped 8% Monday after Hims & Hers said it will pull its copycat weight-loss pill off the market. Novo Nordisk, maker of Wegovy, and the U.S. Food …

Novo Nordisk‘s shift from a market darling to a serious underperformer has set the stage for a transitional 2026 as the Danish drugmaker fights to regain investor confidence in its …

Novo Nordisk has had a tough year: a tumbling stock price resulting in the biggest leadership shakeup in the company’s 100-year history as investors turned thier back on the Danish …

the U.S. Food and Drug management on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker Novo Nordisk, a landmark decision that health experts say could open up …

Zealand Pharma Outlines Ambitious 5-Year Obesity Drug Strategy Amidst Growing Competition Celsopupo | Istock | Getty Images Zealand Pharma on Thursday outlined an ambitious five-year strategy for it’s anti-obesity portfolio …

micron’s Boise Expansion to Create Thousands of Jobs Table of Contents micron’s Boise Expansion to Create Thousands of Jobs Project Details and Investment Job Creation Breakdown Economic Impact on Boise …

Hepatitis B Vaccine Suggestion Under Review Table of Contents Hepatitis B Vaccine Suggestion Under Review The Current Recommendation & Proposed Changes Potential Consequences of a Change Understanding Hepatitis B Why …

President Donald Trump on Thursday struck landmark deals with Eli Lilly and Novo Nordisk that could mark a turning point in how many people can access their costly blockbuster obesity …